All drug development
August 29, 2023
Clinical clue leads to design of promising new solution for chemo-resistant leukemiaA genetic variant associated with better outcomes for leukemia patients suggests a new drug candidate.
February 21, 2022
The truth about patient access and FDA fast-trackingDespite expedited approvals, guidance on patient access to treatments is still significantly delayed
January 19, 2022
‘Decoy’ protein works against multiple SARS-CoV-2 variantsStudy results are reported in the journal Nature Chemical Biology
May 24, 2021
Can antibiotics treat human diseases in addition to bacterial infections?UIC researchers prove that drugs designed for bacteria have potential to act on human cells
November 18, 2020
UIC researchers describe fundamental processes behind movement of magnetic particlesNew study published in Proceedings of the National Academy of Sciences
August 27, 2020
Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effectiveResults published in Breast Cancer Research and Treatment
August 19, 2020
Contraceptive developed at UIC approved by FDA, offers new option for womenUIC attains 4th FDA approval, leads Chicago universities in consumer drug development
July 15, 2020
New antiplatelet drug shows promise for treating heart attackPeptide-derived nanoparticle shows promise in lab
June 19, 2019
UIC’s Institute for Tuberculosis Research tapped to support $28 million drug discovery projectResearchers seek new TB treatments
February 14, 2018
A new class of drug to treat herpes simplex virus infectionDrug works in cells instead of on virus